Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris

Bangladesh Medical Research Council Bulletin

Volumn 33, Issue 3, 2007, Pages 98-102

  Giasuddin, A S M ^a   ElMahdawi, Jamila M ^a   ElHassadi, Fakhri M ^a  

^a AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ACUTE HEART INFARCTION; ACUTE PHASE RESPONSE; ADULT; AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INFLAMMATION; LIBYAN ARAB JAMAHIRIYA; MALE; PATHOGENESIS;

EID: 48049116622     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v33i3.1141     Document Type: Article

References (30)

1. Souhami RL, Moxhan J. Textbook of medicine. 2nd ed. New York, Churchill Livingstone, 1994, pp 390-404.
2. Antman EM, Braunwald E. Acute myocardial infarction. In: Harrison's Principles of internal medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al (eds). 14th ed. New York, McGraw Hill, 1998, pp 1352-65.
3. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol. 2004; 137: 117-22.
4. Erdogan O, Gul C, Altun A, Ozbay G. Increased immunoglobulin E response in acute coronary syndromes. Angiology 2003; 54: 73-79.
5. Hannut R, Duchateau J, Mascart F, Staquet E, Vainsel H, Bernard R. Value of serum immunoglobulin assays in early myocardial infarction. Pathol Biol Paris. 1992: 40: 632-37.
6. Schafer H, Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5b-9 complement complex infarcted areas of human myocardium. J Immunol. 1986; 137: 1945-49.
7. Takahashi M, Masuyama J-I, Ikeda U, Kitagawa S-I, Kasahara T, Saito M, Kano S, Shimada K. Effects of endogenous endothelial interleukin-8 on neutrophil migration across the endothelial monolayer. Cardiovasc Res. 1995; 29: 670-75.
8. Blum A, Sclarovsky S, Rehavia E, Shohat B. Leve of T lymphocyte sub-population, interleukin 1 beta and soluable interleukin 2 receptor in acute myocardial infarction. Am Heart J. 1994; 127: 1226-30.
9. Lucchesi BR. Role of neutrophil in ischemic heart diseases pathophysiologic role in myocardial ischemia and coronary artery perfusion. In: Thrombosis and platelets in myocardial ischemia. Metha JL, Conti RC, Brest AN (eds). Philadelphia, FA Davis Company, 1987, pp 35-48.
10. Vakeva A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S. Time course of complement activation and inhibitor expression after ischemic injury in rat myocardium. Am J Pathol. 1994; 144: 1357-68.
11. Agostoni A, Gardinali M, Frangi D, Cafaro C, Conciato L, Sponzilli C, Salvioni A, Cugno M, Cicardi M. Activation of complement and kinin systems after thrombolytic therapy in patients with acure myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation 1994; 90: 2666-70.
12. Muscari A, Bozzoli C, Puddu GM, Sangiorgi Z, Dormi A, Rovinetti C, Descovich GC, Puddu P. Association of serum C3 levels with the risk of myocardial infarction. Am J Med. 1995; 98: 357-64.
13. Edston E, Hag-Hamstem MV. Immunoglobulin E, mast cell specific tryptase and the complement system in sudden death from coronary artery thrombosis. Int J Cardiol. 1995; 52: 77-81.
14. Ebringer A, Rosenbaum M, Pincus N, Doyle AE. Changes in serum immunoglobulin after myocardial infarction. Am J Med. 1971; 50: 297-301.
15. Holborow EJ, Reeves WG. Immunology in medicine: A comprehensive guide to clinical immunology. London, Academic Press, 1977, pp 573-80.
16. Mancini G, Carbonara AD, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem. 1965; 2: 235-42.
17. Kirkwood BR. Essentials of medical statistics. 1st ed. Oxford, Blackwell Scientific Publications, 1988.
18. Yasuda M, Takeuchi K, Hiruma M, Iida H, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H. The complement system in ischemic heart disease. Circulation 1990; 81: 156-63.
19. Muscari A, Bozzoli C, Massarelli G, Puddu GM, Palareti G, Legnani C, et al. Complement components and fibrinogen: Correlations and association with previous myocardial infarction. Cardiology 1995; 86: 232-37.
20. Frangi D, Gardinali M, Conciato L, Cafaro C, Pozzoni L, Agostoni A. Abrupt complement activation and transient neutropnea in patients with acute myocardial infarction treated with streptokinase. Circulation 1994: 89: 76-80.
21. Shingu M, Nobunaga M. Chemotactic activity generated in human serum from the fifth components of complement by hydrogen peroxide. Am J Pathol. 1984: 117: 201-06.
22. Ember JA, Sanderson SD, Taylor SM, Kawahara M, Hugli TE. Biologic activity of synthetic analogue of C5a anaphylotoxin. J Immunol. 1992; 148: 3165-70.
23. Palikhe A, Sinisalo J, Seppänen M, Haario H, Meri S, Valtonen V, et al. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events. Am J Cardiol. 2007; 99: 890-95.
24. Ito BR, Engler RL, Bazle UD. Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am J Physiol. 1993; 264: H1346-54.
25. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. The role of the complement system in ischemia-reperfusion injury. Shock 2004; 21: 401-09.
26. Homeister JW, Satoh PS. Kilgore KS, Lucchesi BR. Soluble complement receptor type I prevents human complement mediated damage of the rabbit isolated heart. J Immunol. 1993; 150: 1055-64.
27. Iltumur K, Karabulut A, Toprak G, Toprak N. Complement activation in acute coronary syndromes. APMIS 2005; 113: 167-74.
28. Patella V, de Crescenzo G, Ciccarelli A, Marinò I, Adt M, Marone G. Human heart mast cells: A definitive case of mast cell heterogeneity. Int Arch Allergy Immunol. 1995; 106: 386-93.
29. Martin SE, Chenoweth DE, Engler RL, Roth DM, Longhurst JC. Complement C5a decreases regional coronary blood flow and myocardial function in pig: Implications for a granulocyte mechanism. Circ Res. 1988; 63: 483-91.
30. Ito BR, Roth DM, Engler RL. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of C5a. Circ Res. 1990: 66: 596-607.